351 related articles for article (PubMed ID: 30417469)
1. Efficacy and safety of antiviral treatment on blocking the mother-to-child transmission of hepatitis B virus: A meta-analysis.
Song J; Yang F; Wang S; Tikande S; Deng Y; Tang W; Cao G
J Viral Hepat; 2019 Mar; 26(3):397-406. PubMed ID: 30417469
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of telbivudine and tenofovir disoproxil fumarate in preventing hepatitis B vertical transmission: A real-life practice.
Liu J; Wang J; Yan T; Du D; Qi C; Cao F; Yao N; Yang Y; He Y; Tian Z; Ren D; Zhu L; Chen T; Zhao Y
J Viral Hepat; 2019 Oct; 26(10):1170-1177. PubMed ID: 31177596
[TBL] [Abstract][Full Text] [Related]
3. A meta-analysis of lamivudine for interruption of mother-to-child transmission of hepatitis B virus.
Han L; Zhang HW; Xie JX; Zhang Q; Wang HY; Cao GW
World J Gastroenterol; 2011 Oct; 17(38):4321-33. PubMed ID: 22090789
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of antiviral prophylaxis during pregnancy to prevent mother-to-child transmission of hepatitis B virus: a systematic review and meta-analysis.
Funk AL; Lu Y; Yoshida K; Zhao T; Boucheron P; van Holten J; Chou R; Bulterys M; Shimakawa Y
Lancet Infect Dis; 2021 Jan; 21(1):70-84. PubMed ID: 32805200
[TBL] [Abstract][Full Text] [Related]
5. Safety and efficacy of lamivudine or telbivudine started in early pregnancy for mothers with active chronic hepatitis B.
He T; Bai Y; Cai H; Ou X; Liu M; Yi W; Jia J
Hepatol Int; 2018 Mar; 12(2):118-125. PubMed ID: 29344772
[TBL] [Abstract][Full Text] [Related]
6. Decreased neonatal hepatitis B virus (HBV) viremia by maternal tenofovir treatment predicts reduced chronic HBV infection in children born to highly viremic mothers.
Chang KC; Chang MH; Lee CN; Chang CH; Wu JF; Ni YH; Wen WH; Shyu MK; Lai MW; Chen SM; Hu JJ; Lin HH; Hsu JJ; Mu SC; Lin YC; Liu CJ; Chen DS; Lin LH; Chen HL;
Aliment Pharmacol Ther; 2019 Aug; 50(3):306-316. PubMed ID: 31271463
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the efficacy and safety of tenofovir and telbivudine in interrupting mother-to-child transmission of hepatitis B virus.
Zhu B; Lv X; Zhao Z; Chen L; Chen X; Li C; Li S; Dai E
Medicine (Baltimore); 2021 Nov; 100(44):e27695. PubMed ID: 34871254
[TBL] [Abstract][Full Text] [Related]
8. Comparative efficacy of antiviral therapy in preventing vertical transmission of hepatitis B: a network meta-analysis.
Njei B; Gupta N; Ewelukwa O; Ditah I; Foma M; Lim JK
Liver Int; 2016 May; 36(5):634-41. PubMed ID: 26352650
[TBL] [Abstract][Full Text] [Related]
9. Comparison of telbivudine versus lamivudine in interrupting perinatal transmission of hepatitis B virus.
Yu MM; Jiang Q; Ji Y; Wu KH; Ju LL; Tang X; Yang YF
J Clin Virol; 2014 Sep; 61(1):55-60. PubMed ID: 24994007
[TBL] [Abstract][Full Text] [Related]
10. Lamivudine therapy during the second vs the third trimester for preventing transmission of chronic hepatitis B.
Pan CQ; Yi W; Liu M; Wan G; Hu YH; Zhou MF
J Viral Hepat; 2017 Mar; 24(3):246-252. PubMed ID: 28025872
[TBL] [Abstract][Full Text] [Related]
11. Tenofovir to Prevent Hepatitis B Transmission in Mothers with High Viral Load.
Pan CQ; Duan Z; Dai E; Zhang S; Han G; Wang Y; Zhang H; Zou H; Zhu B; Zhao W; Jiang H;
N Engl J Med; 2016 Jun; 374(24):2324-34. PubMed ID: 27305192
[TBL] [Abstract][Full Text] [Related]
12. Prevention of mother-to-child transmission of hepatitis B virus: a phase III, placebo-controlled, double-blind, randomized clinical trial to assess the efficacy and safety of a short course of tenofovir disoproxil fumarate in women with hepatitis B virus e-antigen.
Jourdain G; Ngo-Giang-Huong N; Cressey TR; Hua L; Harrison L; Tierney C; Salvadori N; Decker L; Traisathit P; Sirirungsi W; Khamduang W; Bowonwatanuwong C; Puthanakit T; Siberry GK; Watts DH; Murphy TV; Achalapong J; Hongsiriwon S; Klinbuayaem V; Thongsawat S; Chung RT; Pol S; Chotivanich N
BMC Infect Dis; 2016 Aug; 16():393. PubMed ID: 27506549
[TBL] [Abstract][Full Text] [Related]
13. Telbivudine treatment started in early and middle pregnancy completely blocks HBV vertical transmission.
Sun W; Zhao S; Ma L; Hao A; Zhao B; Zhou L; Li F; Song M
BMC Gastroenterol; 2017 Apr; 17(1):51. PubMed ID: 28407735
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of antiviral therapy for HBV in different trimesters of pregnancy: systematic review and network meta-analysis.
Wu Y; Liu J; Feng Y; Fu S; Ji F; Ge L; Yao N; Luo X; Zhao Y; Chen Y; Yang Y; Chen T
Hepatol Int; 2020 Mar; 14(2):180-189. PubMed ID: 32193814
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of tenofovir in preventing mother-to-infant transmission of hepatitis B virus: a meta-analysis based on 6 studies from China and 3 studies from other countries.
Li W; Jia L; Zhao X; Wu X; Tang H
BMC Gastroenterol; 2018 Aug; 18(1):121. PubMed ID: 30071845
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of tenofovir disoproxil fumarate or telbivudine used throughout pregnancy for the prevention of mother-to-child transmission of hepatitis B virus: A cohort study.
Li Z; Xie B; Yi N; Cai H; Yi W; Gao X
Eur J Obstet Gynecol Reprod Biol; 2022 Sep; 276():102-106. PubMed ID: 35853269
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of antiviral therapy during the second or the third trimester for preventing mother-to-child hepatitis B virus transmission: a systematic review and meta-analysis.
Yang X; Zhong X; Liao H; Lai Y
Rev Inst Med Trop Sao Paulo; 2020; 62():e13. PubMed ID: 32074216
[TBL] [Abstract][Full Text] [Related]
18. A prospective and open-label study for the efficacy and safety of telbivudine in pregnancy for the prevention of perinatal transmission of hepatitis B virus infection.
Han GR; Cao MK; Zhao W; Jiang HX; Wang CM; Bai SF; Yue X; Wang GJ; Tang X; Fang ZX
J Hepatol; 2011 Dec; 55(6):1215-21. PubMed ID: 21703206
[TBL] [Abstract][Full Text] [Related]
19. Lamivudine vs placebo or no treatment in preventing the transmission of hepatitis B virus during pregnancy: a systematic review and meta-analysis.
Zhao P; Qian X; Su C; Yang X; Bai X
Trans R Soc Trop Med Hyg; 2020 Feb; 114(2):121-130. PubMed ID: 31703121
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of tenofovir disoproxil fumarate in pregnancy for the prevention of vertical transmission of HBV infection.
Celen MK; Mert D; Ay M; Dal T; Kaya S; Yildirim N; Gulsun S; Barcin T; Kalkanli S; Dal MS; Ayaz C
World J Gastroenterol; 2013 Dec; 19(48):9377-82. PubMed ID: 24409065
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
